Galafold 123 MG
Ended Awarded
- Contract number
- 36C24524N0329
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89 Part of Amicus Therapeutics, Inc.
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,089
Award facts
- Contract value 100% obligated
- $21,089.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
Amicus Therapeutics US, LLC was awarded a $21,089.47 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule administered by the General Services Administration. The order calls for the delivery of Galafold 123 MG to support healthcare services provided by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 located in Philadelphia, PA. Galafold is used to treat Fabry disease. Amicus Therapeutics, Inc. serves as the prime contractor supporting order fulfillment from its subsidiary Amicus Therapeutics US, LLC. The delivery order was placed without a set-aside designation against Amicus Therapeutics US, LLC's existing Pharmaceuticals and Drugs schedule contract valued at up to $225,000 over five years.
Quick answers
Who was awarded contract 36C24524N0329?
36C24524N0329 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 9, 2024.
How much is contract 36C24524N0329 worth?
The government has obligated $21,089 on 36C24524N0329.
Is contract 36C24524N0329 an order under another contract?
Yes. 36C24524N0329 is a delivery order under 36F79719D0108, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0329 competed?
The extent of competition for 36C24524N0329 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award